endocrinology
Diabetes care

Creatinine increase no reason to stop ACE-inhibitors in T2D patients


ACE inhibitor therapy is worth continuing in patients with type 2 diabetes who show an increase in creatinine levels, despite this usually being a cause for discontinuation, an Australian study suggests. Researchers from the George Institute for Global Health in Sydney say their analysis of data from over 11,000 patients with T2D shows the long-term ...

Already a member?

Enter your email to keep reading.


OR